Filana Therapeutics
FLNA
27 hedge funds and large institutions have $4.33M invested in Filana Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
70% more capital invested
Capital invested by funds: $2.55M → $4.33M (+$1.78M)
8% more funds holding
Funds holding: 25 → 27 (+2)
2.03% more ownership
Funds ownership: 17.39% → 19.41% (+2%)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$321K |
| 2 |
Renaissance Technologies
New York
|
+$58.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$42.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$23.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
-$27.8K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$26K |
| 3 |
VF
Virtu Financial
New York
|
-$25.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9.1K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$6.88K |
FLNA Hedge Fund Activity: Q1 2019 in Review
27 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2019, worth a combined $4.33M — up 70% from $2.55M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FLNA positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Worth Venture Partners, adding an estimated $321K. The largest seller was First Eagle Investment Management, cutting an estimated $27.8K.
- 27 institutional investors held Filana Therapeutics (FLNA) as of Q1 2019, up from 25 in Q4 2018.
- Funds reported $4.33M of Filana Therapeutics stock for Q1 2019, up 70% quarter-over-quarter.
- 3 funds opened new Filana Therapeutics positions in Q1 2019 and 1 closed out, a net change of +2 holders.
- The largest Filana Therapeutics buyer in Q1 2019 was Worth Venture Partners, an estimated $321K added.
- The largest Filana Therapeutics seller in Q1 2019 was First Eagle Investment Management, an estimated $27.8K sold.
Based on aggregated 13F filings for Q1 2019.